THC Farmaceuticals, Inc. (CBDG) Stock

About THC Farmaceuticals, Inc.

THC Farmaceuticals, Inc. specializes in the ownership and operation of independent (non-bank) automated teller machines (ATMs), strategically placing them within third-party retail and commercial establishments. These cash-dispensing units are typically situated in bustling commercial spaces such as hotels, stores, and bowling alleys, aiming for high customer footfall areas that often serve small and medium-sized enterprises. By mid-2015 (June 30), the company reported a network of eight public-access ATMs concentrated in Utah's Wasatch Front region. Founded in 2008 and based in Scottsdale, Arizona, the company adopted its current name, THC Farmaceuticals, Inc., in February 2015, having previously operated as City Media, Inc. THC Farmaceuticals, Inc. functions as a subsidiary of Weed Growth Fund, Inc.

THC Farmaceuticals, Inc. is headquartered in US.

THC Farmaceuticals, Inc. (CBDG) stock trades at $0.03 with a market capitalization of $505872. The stock is valued at a price-to-earnings (P/E) ratio of 46.50, price-to-book of 0.16, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.09, and currently trades 66.7% below its 52-week high.

On profitability, THC Farmaceuticals, Inc. generates a return on equity (ROE) of -0.33%, return on capital employed of -0.77%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.thcpharmaceuticals.com